446 results on '"Baldacci, S."'
Search Results
2. Issue 2 - “Update on adverse respiratory effects of indoor air pollution”. Part 2): Indoor air pollution and respiratory diseases: Perspectives from Italy and some other GARD countries
3. Issue 1 - “Update on adverse respiratory effects of outdoor air pollution”. Part 1): Outdoor air pollution and respiratory diseases: A general update and an Italian perspective
4. Lorlatinib for advanced ROS1+ non-small-cell lung cancer: results of the IFCT-1803 LORLATU study
5. Single breath nitrogen test as predictor of lung function decline and COPD over an 8-year follow-up
6. MA04.03 Osimertinib-induced Epigenetic and Transcriptional Reprogramming Drives a BRD4-POUF-PDGFRB-YAP-EMT Axis of Resistance in NSCLC
7. Traitement des cancers bronchiques non à petites cellules de stades avancés mutés EGFR: quelle(s) séquence(s) ?
8. Prise en charge diagnostique et thérapeutique du mésothéliome pleural malin en 2019
9. Oncogenèse pulmonaire: comprendre les addictions oncogéniques et les résistances
10. Algorithme thérapeutique des cancers bronchiques non à petites cellules étendus avec mutation de l’EGR
11. Les mutations des sites d’épissage de l’exon 14 de MET. Une nouvelle opportunité thérapeutique dans le cancer du poumon
12. Respiratory/Allergic Symptoms in Italian Children Living Close to Cultivations Sprayed With Pesticides
13. Les cancers bronchiques non à petites cellules EGFR-mutés
14. The Po River Delta Epidemiological Survey: Reference Values of Total Serum IgE Levels in a Normal Population Sample of North Italy (8-78 yrs)
15. Algorithme thérapeutique des cancers bronchiques non à petites cellules étendus avec mutation de l’EGR: Therapeutic algorithm of EGFR mutation driven advanced non-small cell carcinoma
16. Oncogenèse pulmonaire : mécanismes généraux et addictions oncogéniques: Pulmonary oncogenesis: General mechanisms and oncogenic addictions
17. Genetic and environmental influences on infant anthropometry at birth and four months of life: evidence from singleton and twin data in the HEALS and earlyFOOD projects
18. Outdoor air pollution and respiratory health
19. Les cancers bronchiques non à petites cellules EGFR-mutés
20. Traitement des cancers bronchiques non à petites cellules de stades avancés mutés EGFR : quels inhibiteurs ? Quelles séquences thérapeutiques ?: EGFR mutation driven advanced non-small cell carcinoma: Which inhibitors? Which therapeutic sequences?
21. Oncogenèse pulmonaire : mécanismes généraux et addictions oncogéniques: Pulmonary oncogenesis: General mechanisms and oncogenic addictions
22. Cancer bronchique
23. Allergy and asthma: Effects of the exposure to particulate matter and biological allergens
24. Exposure to air pollution and allergic diseases in adults
25. Air pollution exposure and prevalence of chronic respiratory diseases in Italy
26. Influence of overweight/obesity, lifestyle and grey space on asthma in Italy
27. RItA: The Italian severe/uncontrolled asthma registry
28. 12-Month Follow-Up of Patients Included in the Italian Severe/Uncontrolled Asthma Registry (RItA)
29. Urban grey spaces are associated with increased allergy in the general population
30. Outdoor air pollution and respiratory diseases: A general update and an Italian perspective
31. 1341P NRAS mutated non-small cell lung cancer (NSCLC) patients: Characteristics and outcomes
32. Risk Factors for Chronic Obstructive Pulmonary Disease in a North Italian Rural Area
33. A Population-Based Study on the Influence of Agricultural and Grey Spaces Proximity on Biomarkers of Exposure and Effect
34. Serum Antibodies Anti-Benzo(a)Pyrene Diol Epoxide-DNA Adducts (BPDE-DNA) and Tobacco Smoking May Predict Respiratory Outcomes in a General Population Follow-Up
35. The severe asthma registries: a way to better know and fight the disease
36. Efficacité et tolérance du lorlatinib en 2e ligne ou plus chez les patients, porteurs d’un cancer bronchique non à petites cellules (CBNPC) avancé ROS1+, traités dans le cadre d’une autorisation temporaire d’utilisation (ATU), étude IFCT-1803 LORLATU
37. Efficacité et tolérance du lorlatinib en 2e ligne ou plus chez les patients, porteurs d’un cancer bronchique non à petites cellules (CBNPC) avancé ALK+, traités dans le cadre d’une autorisation temporaire d’utilisation (ATU), étude IFCT-1803 LORLATU
38. Longitudinal Asthma Patterns in Italian Adult General Population Samples: Host and Environmental Risk Factors
39. Le cause ambientali delle patologie croniche dell’apparato respiratorio
40. Indoor air pollution, physical and comfort parameters related to schoolchildren's health: Data from the European SINPHONIE study
41. RItA: The Italian severe/uncontrolled asthma registry
42. The epidemiological link between ageing and respiratory diseases
43. 1349P Lorlatinib for advanced ROS1+ non-small cell lung cancer (NSCLC): Efficacy and safety data from IFCT-1803 LORLATU expanded access program (EAP) cohort
44. 1303P Lorlatinib for advanced ALK+ non-small cell lung cancer (NSCLC): Efficacy and safety data from IFCT-1803 LORLATU expanded access program (EAP) cohort
45. Greater Risk of Asthma and Allergic Rhinitis, But Not Eczema, Associated with Living Close to Green Space in European Children. The Heals Project
46. Impact de la mise en place de consultations pharmaceutiques dédiées aux thérapies ciblées orales chez les patients atteints de cancer bronchique
47. P2.14-53 High MET Overexpression Does Not Predict the Presence of MET Exon 14 Splice Mutations in NSCLC: Results from the IFCT Predict.amm Study
48. Effects of particulate matter and self-reported risk factors on incidence of airway diseases
49. Indoor and outdoor pollution
50. Number of offspring and maternal allergy
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.